DEA Proposes Rulemaking to Eliminate Hearing Requirement for Bulk Manufacturers

Summary

The US Drug Enforcement Administration (DEA) has proposed a rulemaking to eliminate the mandatory administrative hearing requirement for objections to the registration of bulk manufacturers of controlled substances, while keeping the hearing provision for importers intact.